Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional paid-in capital Amortization of debt discount Restricted Stock [Member] CONSOLIDATED BALANCE SHEETS [Abstract] Net loss per common share - basic (in dollars per share) Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cash equivalents Accounts payable, accrued expenses and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Accrued interest on convertible notes payable and convertible line of credit - related party Increase (Decrease) in Interest Payable, Net Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Changes in operating assets and liabilities: Commitments and Contingencies Common stock, shares authorized (in shares) Common stock, issued (in shares) Issuance of common stock (in shares) Common stock, outstanding (in shares) Common stock shares outstanding (in shares) Common stock, $0.001 par value; 150,000,000 shares authorized at December 31, 2024 and 2023, 63,157,235 and 61,852,914 issued and outstanding at December 31, 2024 and 2023, respectively Convertible Preferred Stock [Member] Total current liabilities Liabilities, Current Current liabilities: Liabilities, Current [Abstract] Convertible Line of Credit - Related Party and Supplemental Lines of Credit - Related Party Convertible Notes Payable - Related Party Debt financing arrangement Interest rate on short term loans Short term borrowing effective interest rate Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Short term borrowing interest rate Interest rate compounded annually Borrowings repayment due date Maturity date Promissory note, maturity date Debt Instrument, Name [Domain] Convertible Notes Payable - Related Party [Abstract] Debt Instrument [Axis] Debt Instrument [Line Items] Schedule of Long-term Debt Instruments [Table] Common stock reserved for future issuance (in shares) Deferred tax assets, gross Deferred Tax Assets, Gross Net deferred tax asset Deferred Tax Assets, Net of Valuation Allowance Operating loss carryforwards Other temporary differences Tax credit carryforwards Less valuation allowance Deferred Tax Assets, Valuation Allowance Security Deposit [Abstract] Deposit Assets [Abstract] Depreciation and amortization expense Change in fair value of derivatives Change in fair value of derivative Change in fair value of derivatives Current portion of derivative liabilities (Note 6) Balance Balance Derivative liabilities (Note 6) Fair value of derivative liability Derivative Liability - Contingent Interest Warrants Derivatives, Policy [Policy Text Block] Net loss per common share - diluted (in dollars per share) Basis of Consolidation Consolidation, Policy [Policy Text Block] Loss from equity method investment Income tax rate, total Effective Income Tax Rate Reconciliation, Percent Primary Factors Affecting Income Tax Rates [Abstract] Effective Income Tax Rate Reconciliation, Percent [Abstract] Changes in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Tax benefit at U.S. statutory rates Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Permanent differences Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent State tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Amortized expense Total stock-based compensation expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Stock-Based Compensation Expense [Abstract] Share-based Payment Arrangement, Noncash Expense [Abstract] Shares issued (in shares) Federal [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Furniture and Fixtures [Member] General and administrative General and Administrative [Member] General and Administrative Expense [Member] Impairment of long-lived assets Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Income Taxes Income Taxes Income Tax, Policy [Policy Text Block] Research and development credits Amortization of interest expense Accrued interest expense Interest Expense, Debt Additional interest expense Interest Expense, Other Leasehold Improvements [Member] Total liabilities Liabilities Total liabilities, redeemable convertible preferred stock and stockholders' deficit Liabilities and Equity LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities and Equity [Abstract] Line of credit Line of Credit Facility, Maximum Borrowing Capacity Convertible Line of Credit - Related Party and Supplemental Lines of Credit - Related Party [Abstract] Line of Credit Facility [Line Items] Line of Credit Facility [Table] Line of Credit [Member] Line of Credit [Member] Line of Credit [Member] Convertible Notes Payable - Related Party [Member] Vendors disputed claim amount Loss Contingency, Estimate of Possible Loss Ownership percentage Subsidiary, Ownership Percentage, Parent Related and Nonrelated Parties [Axis] Net cash from financing activities Net Cash Provided by (Used in) Financing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net cash from investing activities CASH FLOWS FROM INVESTING ACTIVITIES: Net cash from operating activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Net loss Net loss Net loss applicable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic New Accounting Pronouncements or Change in Accounting Principle [Line Items] Accounting Standards Update and Change in Accounting Principle [Table] Total other expense Nonoperating Income (Expense) Other income (expense): Other income (expense) [Abstract] Net operating loss carryforwards Total operating loss Operating Income (Loss) Nature of Business, Basis of Presentation, Liquidity, and Going Concern Series A 12% convertible preferred stock, shares authorized (in shares) Convertible preferred stock, shares authorized (in shares) Series A 12% convertible preferred stock, shares issued (in shares) Series A 12% convertible preferred stock, shares outstanding (in shares) Preferred stock dividends Preferred Stock Dividends and Other Adjustments Preferred stock par value (in dollars per share) Gross proceeds from issuance of preferred stock Proceeds from Issuance of Redeemable Convertible Preferred Stock Proceeds from lines of credit Net proceeds from convertible line of credit - related party Proceeds from Lines of Credit Property and equipment Property, Plant and Equipment, Gross Property and equipment, net Property and equipment - net Property and Equipment [Abstract] Property and Equipment [Abstract] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Initial cash investment Related and Nonrelated Parties [Domain] Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Retained deficit Components of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Property and Equipment Property, Plant and Equipment [Table Text Block] Security deposit for leased office space Security deposit Segments Summary of Significant Expense Categories and Asset Categories Segment Reporting Information [Line Items] Schedule of Segment Reporting Information, by Segment [Table] Series C 6% Super Dividend Redeemable Convertible Preferred Stock [Member] Series C 6% Super Dividend Redeemable Convertible Preferred Stock [Member] Series A 12% Convertible Preferred Stock [Member] Canceled/Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Restricted stock awards granted (in shares) Issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Unrecognized compensation cost Unrecognized compensation cost Options Exercisable, Number of Shares (in shares) Exercise Price Range [Domain] Exercise Price Range [Axis] Options Outstanding, Number of Shares (in shares) Maximum Exercise Price (in dollars per share) Number of shares authorized for issuance (in shares) Stock awards, available for future grant (in shares) Forfeited/cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Weighted-average grant-date fair values of options granted (in dollars per share) Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Outstanding at end of period (in shares) Outstanding at beginning of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Outstanding at beginning of period (in dollars per share) Outstanding at beginning of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Exercisable, end of period (in shares) Exercisable, end of period (in dollars per share) Expected dividend Expected dividend rate Expected dividend yield used in the option valuation model Expected volatility Expected volatility of the underlying stock Risk free interest rate Risk-free interest rate Award Type [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Outstanding and Exercisable Options under Stock Based Compensation Plans Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Summary of Significant Accounting Policies State [Member] CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) [Abstract] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Transaction costs Stockholders' equity (deficit): Equity, Attributable to Parent [Abstract] Stockholders' Equity [Abstract] Stockholders' Equity Note [Abstract] Number outstanding (in shares) Stockholders' Equity Warrants to purchase common stock (in shares) Subsequent Event Type [Axis] Subsequent Event [Line Items] Subsequent Event [Table] Subsequent Event Type [Domain] Total current assets Assets, Current Current assets: Assets, Current [Abstract] Warrants [Member] Warrants [Member] Weighted average common and potential common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average common and potential common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Common Stock [Member] Property and Equipment Long-Lived Tangible Asset [Domain] Research and development Convertible Notes Payable - Related Party [Member] Convertible Notes Payable [Member] Preferred Stock [Member] Total assets Assets Interest income Other liabilities Preferred stock redemption price (in dollars per share) Income Tax Authority [Domain] Financial Instruments [Domain] Stock-Based Compensation Significant Expense Categories [Abstract] Statement [Table] Antidilutive Securities, Name [Domain] ASSETS Assets [Abstract] Statement [Line Items] Roll Forward of Derivative Liability - Contingent Interest Roll Forward of Derivative Liability [Roll Forward] Summary of Warrants Activity, Outstanding Warrants Issued in Connection with Equity and Debt Financings and Consultants Class of Warrant or Right [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Level 1 [Member] Level 2 [Member] Level 3 [Member] Estimated fair value of asset contributed to joint venture Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure Stockholders' Equity [Abstract] Fair Value of Financial Instruments Series C 6% super dividend redeemable convertible preferred stock, shares authorized (in shares) Series C 6% super dividend redeemable convertible preferred stock, shares issued (in shares) Series C 6% super dividend redeemable convertible preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Stated value of dividend payment (in dollars per share) Preferred Stock, Liquidation Preference Per Share Class of Warrant or Right [Line Items] Class of Stock [Domain] Outstanding Warrants [Abstract] Common Stock Warrants Purchase Agreement [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Property and Equipment [Abstract] Property, Plant and Equipment, Net, by Type [Abstract] Issuance of common stock purchase warrants in connection with related party line of credit Adjustments to Additional Paid in Capital, Warrant Issued Shares unissued (in shares) Other Other Assets, Noncurrent Operating expenses: Operating expenses [Abstract] Total operating expenses Operating Expenses Amount excluded from calculation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Loss Per Share [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Abstract] Earnings Per Share, Diluted, Other Disclosure [Abstract] Deemed dividend Preferred Stock Redemption Premium Additional accrued amount Loss Contingency, Range of Possible Loss, Portion Not Accrued Class of Stock [Axis] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Property, Plant and Equipment [Table] Common stock, par value (in dollars per share) Long-Lived Tangible Asset [Axis] Property, Plant and Equipment [Line Items] Total stockholders' deficit Beginning balance Ending balance Equity, Attributable to Parent Series A 12% convertible preferred stock; 1,742,500 shares authorized, 1,235,000 and 1,235,000 issued and outstanding at December 31, 2024 and 2023, respectively, liquidation value $1,235,000 at December 31, 2024 Preferred Stock, Value, Issued Redeemable Convertible Preferred Stock [Abstract] Warrant liabilities Equity Components [Axis] Additional Paid-in Capital [Member] Retained Deficit [Member] Equity Component [Domain] Minimum Exercise Price (in dollars per share) Common Stock Weighted average Grant Date fair Value (in dollars per share) Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] Deferred Bonus [Member] Stock Options [Member] Non-cash interest expense Restricted stock units valued at grant Stock Issued During Period, Value, Restricted Stock Award, Gross Issuance of common stock from exercise of stock options, net of shares withheld for exercise Conversion of Series A Convertible Preferred to common Stock Issued During Period, Value, Conversion of Convertible Securities Preferred stock issued (in shares) Stock Issued During Period, Shares, New Issues Issuance of common stock from restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Stock-based compensation expense (in shares) Exercised (in shares) Issuance of common stock from exercise of stock options, net of shares withheld for exercise (in shares) Conversion of Series A Convertible Preferred to common (in shares) Common stock, shares issued (in shares) Segments [Axis] NONCASH FINANCING ACTIVITIES: Stock Option Activity [Roll Forward] Warrants Activity [Roll Forward] Fair Value Assumptions Before and After Extension of warrants [Abstract] Weighted Average Assumptions for Stock Options Granted [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Convertible preferred stock dividend Loss Per Share Class of Stock [Line Items] Stock, Class of Stock [Table] Commitments and contingencies (Note 12) Adjustments to reconcile net loss to net cash from operating activities: Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Accounts payable Total Accrued expenses Legal and accounting fees Accrued dividends payable Accrued compensation Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Stock-based compensation expense Galectin Sciences LLC Prepaid expenses and other current assets Series C 6% super dividend redeemable convertible preferred stock, redemption value Convertible preferred stock, redemption value Increase (Decrease) in Temporary Equity [Roll Forward] Series C 6% super dividend redeemable convertible preferred stock liquidation value Assets Assets, Fair Value Disclosure Segments [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Recurring [Member] Income tax payment withholding Net proceeds from exercise of common stock options and warrants Shares withheld to cover income tax withholding (in shares) Accrued Expenses [Abstract] Nature of Business, Basis of Presentation, Liquidity, and Going Concern [Abstract] Preferred stock, dividend rate Preferred stock, dividend rate Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Convertible note payable repayment Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Components of Net Deferred Tax Assets Primary Factors Affecting Income Tax Rates Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Commitments and Contingencies [Abstract] Income Taxes [Abstract] Fair Value of Financial Instruments [Abstract] Subsequent Event Investments in and Advances to Affiliates, Schedule of Investments [Abstract] Stock Option Activity Weighted Average Assumptions Used to Determine Fair Value of Options Granted Stock-Based Compensation [Abstract] Reclassification of accrued compensation to additional paid in capital Use of Estimates Use of Estimates, Policy [Policy Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Key Assumptions Used in Model at Inception Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Research and Development [Member] Research and Development Expense [Member] Summary of Significant Accounting Policies [Abstract] Segments [Abstract] Subsequent Event [Abstract] Common stock issued upon conversion (in shares) Preferred stock shares upon conversion (in shares) Convertible preferred stock (in shares) Convertible note principal Exercisable date Class of Warrant or Right, Date from which Warrants or Rights Exercisable Payment of preferred stock dividends in common stock Stock Issued Derivative Instrument [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Income Tax Authority [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options Exercisable, Number of Shares (in dollars per share) Options Outstanding, Weighted Average Exercise Price (in dollars per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Exercisable, end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Deferred Tax Assets [Abstract] Closing price (in dollars per share) Share price (in dollars per share) Minimum closing price of common stock (in dollars per share) Financial Instrument [Axis] Series C 6% super dividend redeemable convertible preferred stock; 1,000 shares authorized, 176 issued and outstanding at December 31, 2024 and 2023, redemption value: $8,018,000, liquidation value: $1,760,000 at December 31, 2024 Beginning balance Ending balance Weighted Average Exercise Price [Abstract] Granted (in dollars per share) Exercised (in dollars per share) Forfeited/cancelled (in dollars per share) Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized [Abstract] Plan Name [Axis] Plan Name [Domain] Award Type [Axis] Subsequent Event [Member] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Stock based compensation expense Deferred Compensation Arrangement with Individual, Allocated Share-Based Compensation Expense Series A 12% convertible preferred stock, liquidation value Recent Accounting Standards Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Credit Facility [Axis] Credit Facility [Domain] Estimated useful life Exercisable, end of the period Expected life Expected life of the options Unrecognized compensation cost, recognition period Outstanding end of the period Options Outstanding, Weighted Average Remaining Contractual Life Number of operating segment Number of Operating Segments Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Conversion price (in dollars per share) Derivative Contract [Domain] Investments in and Advances to Affiliates [Line Items] Schedule of Investments [Table] IPR&D [Member] Assets and Liabilities Measured at Fair Value [Abstract] Number of shares issued upon exercise of warrant (in shares) Shares issued, price (in dollars per share) Shares Issued, Price Per Share Change in fair value of derivatives Fair Value Adjustment Fair Value Adjustment of Warrants Total fair value of options vested Additional short term borrowing interest rate Term Liabilities Financial Liabilities Fair Value Disclosure Unvested option (in shares) Options vested (in shares) Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain] Tax Period [Axis] Tax Period [Domain] Exercise price (in dollars per share) Exercise price of warrant (in dollars per share) Federal and Sate [Abstract] Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Lease cost Right to use lease asset Maturity of Operating Lease [Abstract] Discount rate on present value of lease payments Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Lease Commitments [Abstract] NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS Amount expanded in cash CASH AND CASH EQUIVALENTS, END OF PERIOD CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Total Lessee, Operating Lease, Liability, to be Paid 2025 Maturity of Operating Lease Present value of lease liability Operating Lease, Liability Lease liability Current lease liability Less imputed interest Non-current lease liability Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Galectin Sciences LLC [Abstract] Measurement Input Type [Axis] Conversion Price of Conversion Feature [Member] Credit Adjusted Discount Rate [Member] Dividend Rate [Member] Term [Member] Volatility [Member] Risk Free Interest Rate [Member] Stock Price [Member] Measurement Input Type [Domain] Key Assumptions [Abstract] Derivative liability, measurement input Derivative Liability, Measurement Input Term of contract Lease renewal term Lessee, Operating Lease, Renewal Term Fair Value, Inputs, Level 1, 2 and 3 [Member] Weighted average expiration term of warrants outstanding Warrants and Rights Outstanding, Term Warrants expiry date Amortization of right to use asset Long-Lived Assets [Abstract] Interest expense Interest Expense, Nonoperating Title and Position [Domain] Richard E. Uihlein [Member] Chief Executive Officer [Member] Scenario [Domain] Forecast [Member] Scenario [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Minimum [Member] Counterparty Name [Axis] Counterparty Name [Domain] Title and Position [Axis] Ownership [Axis] Ownership [Domain] Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Cover [Abstract] Document Type Document Annual Report Document Transition Report Document Financial Statement Error Correction [Flag] Entity Interactive Data Current Amendment Flag ICFR Auditor Attestation Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Shell Company Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Public Float Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Auditor Name Auditor Firm ID Auditor Location Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development costs and other. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research and Development Costs and Other Current Accrued research and development costs and other Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Term [Abstract] Weighted Average Remaining Contractual Life [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value [Abstract] Options Outstanding [Abstract] Options Exercisable [Abstract] Its represented to exercise price range two. Exercise Price Range Two [Member] $1.01-$3.00 [Member] Its represented to exercise price range three. Exercise Price Range Three [Member] $3.01-$5.00 [Member] Its represented to exercise price range one. Exercise Price Range One [Member] $0.87-$1.00 [Member] Its represented to exercise price range four. Exercise Price Range Four [Member] $5.01 - $8.00 [Member] Its represented to exercise price range five. Exercise Price Range Five [Member] $8.01-$13.38 [Member] Amount of expense (income) related to adjustment to fair value of warrant liability. Fair Value Adjustment of Warrant Warrant modification Warrants [Abstract] Warrants [Abstract] The entire disclosure for Equity warrants are instruments that bestow upon the holder of the instrument the right to buy a particular stock at a predetermined price within a stipulated time frame. ... This payment is to be adjusted against the final payment that needs to be paid in case the warrants are exercised. Common Stock Warrants Disclosure [Text Block] Warrants Restricted Stock Grants [Abstract] Percentage of underlying the outstanding whole number of DSUs credited individuals during period. Deferred Compensation Arrangement, Percentage of Deferred Share Units Shall be Issued, Period One Percentage of DSUs shall be credited on March 1, 2023 Percentage of underlying the outstanding whole number of DSUs credited individuals during period. Deferred Compensation Arrangement, Percentage of Deferred Share Units Shall be Issued, Period Six Percentage of DSUs shall be credited on March 1, 2025 The deferred compensation arrangement with individual cash award granted paid in cash percentage. Deferred Compensation Arrangement With Individual Cash Award Granted Paid in Cash Percent Percentage of base salary paid in cash Percentage of underlying the outstanding whole number of DSUs credited individuals during period. Deferred Compensation Arrangement, Percentage of Deferred Share Units Shall be Issued, Period Five Percentage of DSUs shall be credited on March 1, 2023 Percentage of underlying the outstanding whole number of DSUs credited individuals during period. Deferred Compensation Arrangement, Percentage of Deferred Share Units Shall be Issued, Period Seven Percentage of DSUs shall be credited on January 5, 2026 Percentage of underlying the outstanding whole number of DSUs credited individuals during period. Deferred Compensation Arrangement Percentage of Deferred Share Units Shall be Issued Period Three Percentage of DSUs shall be credited on September 1, 2028 Percentage of underlying the outstanding whole number of DSUs credited individuals during period. Deferred Compensation Arrangement Percentage of Deferred Share Units Shall be Issued Period Two Percentage of DSUs shall be credited on March 1, 2024 Percentage of underlying the outstanding whole number of DSUs credited individuals during period. Deferred Compensation Arrangement, Percentage of Deferred Share Units Shall be Issued, Period Four Percentage of DSUs shall be credited on March 1, 2024 Bonus shares are additional shares given to the existing shareholders. Bonus Shares [Member] Bonus Shares [Member] The deferred compensation arrangement with individual cash award granted paid in deferred stock units percentage. Deferred Compensation Arrangement With Individual Cash Award Granted Paid in Deferred Stock Units Percent Percentage of base salary paid in deferred stock units Name of the class or type of warrants. May Twenty Three Twenty Ninteen Rights Offering Warrants [Member] May 23, 2019 Rights Offering warrants [Member] Name of the class or type of warrants. March 29, 2024 Warrants Issued for Draw on Related Party Line of Credit [Member] March 29, 2024 Warrants Issued for Draw on Related Party Line of Credit [Member] Name of the class or type of warrants. June 28, 2024 Warrants Issued for Draw on Related Party Line of Credit [Member] June 28, 2024 Warrants Issued for Draw on Related Party Line of Credit [Member] Name of the class or type of warrants. September Thirty Twenty Zero Nine Series B Two Transaction One [Member] September 30, 2009 Series B-2 Transaction [Member] Name of the class or type of warrants. December 29, 2023 Warrants Issued for Draw on Related Party Line of Credit [Member] December 29, 2023 Warrants Issued for Draw on Related Party Line of Credit [Member] Name of the class or type of warrants. August Twelve Twenty Zero Nine Series B Two Transaction One [Member] August 12, 2009 Series B-2 Transaction [Member] Name of the class or type of warrants. July 22, 2022 Warrants Issued in Connection with Related Party Line of Credit [Member] July 22, 2022 Warrants Issued in Connection with Related Party Line of Credit [Member] Name of the class or type of warrants. May Ten Twenty Ten Series B Two Transaction Two [Member] May 10, 2010 Series B-2 Transaction [Member] Name of the class or type of warrants. April Thirty Twenty Ten Series B Two Transaction One [Member] April 30, 2010 Series B-2 Transaction [Member] Name of the class or type of warrants. Twenty Eighteen And Twenty Seventeen Warrants Issued For Services [Member] 2018 and 2017 Warrants issued for services [Member] Name of the class or type of warrants. December Eight Twenty Zero Nine Series B Two Transaction One [Member] December 8, 2009 Series B-2 Transaction [Member] Name of the class or type of warrants. January Twenty Nine Twenty Ten Series B Two Transaction One [Member] January 29, 2010 Series B-2 Transaction [Member] Name of the class or type of warrants. February Twelve Two Thousand Zero Nine Series B One Transaction Member February 12, 2009 Series B-1 Transaction [Member] Name of the class or type of warrants. December Twenty Three Twenty Sixteen Series B Three Transaction [Member] December 23, 2016 Series B-3 Transaction [Member] Name of the class or type of warrants. September 30, 2024 Warrants Issued for Draw on Related Party Line of Credit [Member] September 30, 2024 Warrants Issued for Draw on Related Party Line of Credit [Member] Name of the class or type of warrants. September Twenty Nine Twenty Sixteen Series B Three Transaction [Member] September 29, 2016 Series B-3 Transaction [Member] Name of the class or type of warrants. November Four Twenty Zero Nine Series B Two Transaction One [Member] November 4, 2009 Series B-2 Transaction [Member] Name of the class or type of warrants. September Twenty Two Twenty Sixteen Series B Three Transaction [Member] September 22, 2016 Series B-3 Transaction [Member] Date the warrants or rights are expired, in YYYY-MM-DD format. Class Of Warrant Or Rights Date From Which Warrants Or Rights Expired Expiration date Name of the class or type of warrants. March Eight Twenty Ten Series B Two Transaction Two [Member] March 8, 2010 Series B-2 Transaction [Member] Name of the class or type of warrants. January Twenty Nine Twenty Ten Series B Two Transaction Two [Member] January 29, 2010 Series B-2 Transaction [Member] Name of the class or type of warrants. March Eight Twenty Ten Series B Two Transaction One [Member] March 8, 2010 Series B-2 Transaction [Member] Date the warrants or rights are issued, in YYYY-MM-DD format. Warrant Issue Date Warrant issue date Name of the class or type of warrants. April Thirty Twenty Ten Series B Two Transaction Two [Member] April 30, 2010 Series B-2 Transaction [Member] Name of the class or type of warrants. May Ten Twenty Ten Series B Two Transaction One [Member] May 10, 2010 Series B-2 Transaction [Member] Name of the class or type of warrants. June Thirty Twenty Zero Nine Series B Two Transaction One [Member] June 30, 2009 Series B-2 Transaction [Member] Issuance price per share or per unit of warrants or rights outstanding. Warrants Issued Price Warrants issued price (in dollars per share) Name of the class or type of warrants. May Thirteen Twenty Zero Nine Series B Two Transaction One [Member] May 13, 2009 Series B-2 Transaction [Member] 'The vesting percentage of Restricted Stock Units ("RSUs") granted. Vesting Percentage of Restricted Stock Units Vesting percentage of Restricted Stock Units Number of directors of the company. Number of Directors Class of security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Series B Warrants [Member] Period of specified trading days that common stock price must exceed threshold price for specified number of trading days, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Number of Trading Days to be Considered Stock Closing Price in Purchase Agreement Number of consecutive trading days to be considered in purchase agreement Threshold period for stock closing price in ten consecutive days under purchase warrants agreement in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Period for Stock Closing Price in Ten Consecutive Days under Purchase Warrants Agreement Threshold period for stock closing price in 10 consecutive days under purchase warrants agreement Number of prior notice days required that would bar the voluntary exercise of any warrants that would result in beneficial ownership beyond specified percentage, in P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period of Prior Notice that Would Bar Voluntary Exercise of any Warrants Period of prior notice that would bar voluntary exercise of any warrants Threshold period for extension of exercise date of common stock purchase warrants under purchase agreement in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Period for Extension of Exercise Date of Purchase Warrants under Agreement Threshold period for extension of exercise date of purchase warrants under purchase agreement Name of beneficial owner. 10X Fund L.P [Member] Name of beneficial ownership entity. 10X Fund L.P., and 10X Capital Management LLC [Member] Beneficial ownership percentage of the outstanding shares of the Company's Class A common stock that would allow warrants to be settled in cash upon the occurrence of a tender offer or exchange offer. Beneficial Ownership Percentage Beneficial ownership percentage Change in fair value of the warrants immediately before the modification. Before Modification [Member] Before Modification [Member] Change in fair value of the warrants immediately after the modification. After Modification [Member] After Modification [Member] Amount of increase (decrease) in equity for Warrants classified as equity from modification. Warrant Modification, Increase (Decrease) in Equity, Amount Warrant modification Amount of paid and unpaid temporary equity dividends declared with the form of settlement in cash. Temporary Equity Dividends Series C super dividend redeemable convertible preferred stock dividend Amount of paid and unpaid convertible preferred stock dividends declared with the form of settlement in cash. Convertible Preferred Stock, Dividends Series A 12% convertible preferred stock dividend Number of shares of Convertible preferred stock issued as dividends during the period. Excludes stock splits. Convertible Preferred Stock Dividends, Shares Series A 12% convertible preferred stock dividend (in shares) Number of shares of common stock issued as dividends for temporary equity during the period. Temporary Equity Dividends, Shares Series C super dividend redeemable convertible preferred stock dividend (in shares) Equity impact of the value of stock issued from the exercise of warrants. Stock Issued During Period Value Warrant Exercise Issuance of common stock from exercise of warrants Number of new stock issued upon the exercise of warrants during the period. Stock Issued During Period Shares Warrant Exercise Issuance of common stock from exercise of warrants (in shares) The derivative liability of contingent interest December Note. Contingent Interest, December Note [Member] December Note [Member] The derivative liability of contingent interest September Note. Contingent Interest, September Note [Member] September Note [Member] The derivative liability of contingent interest April Note. Contingent Interest, April Note [Member] April Note [Member] Information about non qualified options Plans. Non Qualified Options Plans [Member] Equity Incentive Plan Agreement ("Agreement") is a legal contract between a Corporation and its employees to provide the employee with an interest in the Corporation. The purpose of an Equity Incentive Plan is to strengthen the financials of the Corporation by providing incentive stock options to its employees. Incentive Compensation Plan Two thousand Nine Member [Member] Incentive Compensation Plan 2009 [Member] A share-based compensation plan under which awards may be granted for officers, employees and directors of the Company and its subsidiaries. Equity Incentive Plan 2019 [Member] Amount reclassified from accrued compensation to excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. Reclassification Of Accrued Bonus To Additional Paid In Capital Reclassification of accrued bonus to additional paid in capital The fair value of common stock purchase warrants issued in connection with related party line of credit in noncash financing activities. Common Stock Purchase Warrants Issued in Connection with Related Party Line of Credit Common stock purchase warrants issued in connection with related party line of credit Return on Investments Percentage [Abstract] ROI Percentage [Abstract] Return on investments percentage before second anniversary of date of issuance. Return on Investments Percentage, Period One ROI before second anniversary of date of issuance Return on investments after second anniversary but before third anniversary of date of issuance. Return on Investments Percentage, Period Two ROI after second anniversary but before third anniversary of date of issuance Return on investments after eighth anniversary but before ninth anniversary of date of issuance. Return on Investments Percentage, Period Eight ROI after eighth anniversary but before ninth anniversary of date of issuance Return on investments after sixth anniversary but before seventh anniversary of date of issuance. Return on Investments Percentage, Period Six ROI after sixth anniversary but before seventh anniversary of date of issuance Return on investments after seventh anniversary but before eighth anniversary of date of issuance. Return on Investments Percentage, Period Seven ROI after seventh anniversary but before eighth anniversary of date of issuance Return on investments after third anniversary but before fourth anniversary of date of issuance. Return on Investments Percentage, Period Three ROI after third anniversary but before fourth anniversary of date of issuance Number of voting rights of convertible preferred stock. Includes eligibility to vote and votes per share owned. Convertible Preferred Stock, Number of Voting Rights Convertible preferred stock, voting rights Return on investments after fourth anniversary but before fifth anniversary of date of issuance. Return on Investments Percentage, Period Four ROI after fourth anniversary but before fifth anniversary of date of issuance Return on investments after fifth anniversary but before sixth anniversary of date of issuance. Return on Investments Percentage, Period Five ROI after fifth anniversary but before sixth anniversary of date of issuance Agreement with a sales agent under which the Company may issue and sell shares of its common stock. Two Thousand Twenty Market Agreement [Member] 2020 Market Agreement [Member] Agreement with a sales agent under which the Company may issue and sell shares of its common stock. Two Thousand Seventeen Market Agreement [Member] 2017 Market Agreement [Member] Percentage of commission rate to be paid to sales agent in gross proceeds from the sale of common stock. Commission Rate Percentage of commission rate to be paid to sales agent The maximum number of undesignated capital stock permitted to be issued by an entity's charter and bylaws. Undesignated Capital Stock, Shares Authorized Undesignated stock, shares authorized (in shares) Amount of aggregate offering price of common stock which can be sold from time to time through the sales agent. Aggregate Offering Price Aggregate offering price Series B-2 Preferred stock that may be exchanged into common shares or other types of securities at the owner's option. Each share of the Series B-2 is entitled to dividends at the rate of 12% per annum. Series B Two Convertible Preferred Stock [Member] Series B-2 Convertible Preferred Stock [Member] Series B-1 Preferred stock that may be exchanged into common shares or other types of securities at the owner's option. Each share of the Series B-1 is entitled to dividends at the rate of 12% per annum. Series B One Convertible Preferred Stock [Member] Series B-1 Convertible Preferred Stock [Member] Series B-3 Preferred stock that may be exchanged into common shares or other types of securities at the owner's option. Each share of the Series B-3 is entitled to dividends at the rate of 8% per annum. Series B Three Convertible Preferred Stock [Member] Series B-3 Convertible Preferred Stock [Member] Aggregate par or stated value of shares which are not designated as common stock or preferred stock. Undesignated Capital Stock Value Undesignated stock, $0.01 par value; 20,000,000 shares authorized at December 31, 2024 and 2023, 20,000,000 shares designated at December 31, 2024 and 2023, respectively Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as borrowing and accrued interest under line of credit related party excluding current portion. Borrowing and Accrued Interest Under Line of Credit, Net of Debt Discount, Related Party Noncurrent Borrowing and accrued interest under convertible line of credit, net of debt discount - related party (Note 10) Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as convertible notes payable and accrued interest, net of debt discount of related party excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. Convertible Note Payable and Accrued Interest Net of Debt Discount - Related Party Non-Current Convertible notes payable and accrued interest, net of debt discounts - related party (Note 5) Carrying value as of the balance sheet date of current portion of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as convertible notes payable and accrued interest, net of debt discount of related party. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. Convertible Note Payable And Accrued Interest Net Of Debt Discount Related Party Current Current portion of convertible notes payable and accrued interest, net of debt discounts - related party (Note 5) Number of shares of undesignated capital stock which are designated as common stock or preferred stock by board of directors. Undesignated Capital Stock Shares Designated Undesignated stock, shares designated (in shares) Face amount or stated value per share of undesignated capital stock. Undesignated Capital Stock Par Value Undesignated stock, par value (in dollars per share) Share based Compensation Arrangement by Share based Payment Award Equity Instruments Other Than Options Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price [Abstract] Weighted average price at which option holders acquired shares granted when converting their stock options into shares. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Weighted Average Exercise Price Issued (in dollars per share) Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price Outstanding at end of period (in dollars per share) Outstanding at beginning of period (in dollars per share) Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Share based Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeitures In Period Weighted Average Exercise Price Canceled/Expired (in dollars per share) Weighted average price at which option holders acquired shares when converting their stock options into shares. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Exercise Price Exercised (in dollars per share) Name of counterparty. A counterparty is the other party that participates in a financial transaction. SBH Sciences, Inc. [Member] SBH [Member] The amount of non-cash charge in research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. Non-cash Charge for Research and Development in Process Non-cash charge for in-process research and development Capital contribution expense. Capital Contribution Expense Contribution for expenses Name of entity. Galectin Sciences, LLC [Member] Galectin Sciences, LLC [Member] Nature of Business, Basis of Presentations and Liquidity [Abstract] Nature of Business, Basis of Presentation and Liquidity [Abstract] Number of available line of credit facility borrowings. Number of Line of Credit Number of line of credit A supplemental contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars. Supplemental Line of Credit [Member] Supplemental Line of Credit [Member] Convertible Notes Payable, Related Party [Abstract] Convertible Notes Payable - Related Party [Abstract] The number of promissory notes executed under the loans agreement. Number of Promissory Notes Executed Number of promissory notes executed The number of loans closing under the loans agreement. Number of Loans Closing Number of loans closing Contingent interest rate per annum for funds borrowed, under the debt agreement. Annual Interest Rate Additional interest rate per annum from issuance date to maturity date period Contingent interest rate per quarter for funds borrowed, under the debt agreement. Quarterly Interest Rate Additional interest rate per quarter The type of debt instrument. April Convertible Promissory Note [Member] April 2021 Note [Member] A type of debt instrument. September Convertible Promissory Note [Member] September 2021 Note [Member] A type of debt instrument. First Closing [Member] A type of debt instrument. Second Closing [Member] The type of debt instrument. December Convertible Promissory Note [Member] December 2021 Note [Member] The number of promissory notes evidenced by loans agreement. Number of Promissory Notes Evidenced by Loans Agreement Number of promissory notes evidenced by loans agreement Disclosure of accounting policy for prepaid expenses and other current assets. Prepaid Expenses and Other Current Assets [Policy Text Block] Prepaid Expenses and Other Current Assets Disclosure of accounting policy for security deposit. Security Deposit [Policy Text Block] Security Deposit Disclosure of accounting policy for accrued expense. Accrued Expense [Policy Text Block] Accrued Expenses Long lived, depreciable assets in the form of computer and office equipment. Computer and Office Equipment [Member] Computer and Office Equipment [Member] Number of days for preferred stock post conversion rights in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but not limited to, weeks in a year or quarter. Closing Days After Conversion Rights Closing days after conversion rights Multiplied by the preferred stock post conversion redemption right shall be equal the applicable return on investment ("ROI") percentage. Post Conversion Redemption Right Return on Investment Multiplier Amount Post conversion redemption right, return on investment multiplier amount Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities. Equity Issuance Per Share Amount Common stock share conversion price (in dollars per share) Shares of Series C were converted into common stock and post conversion dividend rights were issued. Post Conversion Dividend Rights Issued Post conversion dividend rights (in shares) Dividend payment scenario. Dividend Payment Scenario Two [Member] Dividend Payment Scenario Two [Member] Scenario 2 [Member] Net sales until the total dividends paid is equal to the initial investment as percentage of total net sales. Dividend as Percentage of Net Sales Dividend as percentage of net sales Number of consecutive trading days, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but not limited to, weeks in a year or quarter. Number of Consecutive Trading Days Number of consecutive trading days Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. Proceeds from Issuance of Preferred Stock, Net of Issuance Costs Net proceeds from issuance of preferred stock Dividend payment scenario. Dividend Payment Scenario One [Member] Dividend Payment Scenario One [Member] Scenario 1 [Member] Common stock issued per each converted share of Series C (accrued and unpaid dividends will be issued as additional shares). Common Shares Issuable Upon Conversion of Convertible Stock Common stock shares issued (in shares) Number of warrants or rights issued during the period. Class of Warrant or Right Issued Warrants issued (in shares) Promissory note executed on September 30, 2024 under the line of credit agreement. September 2024 Promissory Note [Member] September 2024 Promissory Note [Member] Promissory note executed on June 30, 2023 under the line of credit agreement. March 2024 Promissory Note [Member] March 2024 Promissory Note [Member] Promissory note executed on June 30, 2023 under the line of credit agreement. June 2023 Promissory Note [Member] Promissory note executed on December 19, 2022 under the line of credit agreement. December 2022 Promissory Note [Member] Line of Credit, Related Party [Abstract] Convertible Line of Credit - Related Party [Abstract] Accrued, but unpaid interest on the debt instrument. Debt Instrument, Accrued Interest Accrued interest The amount of issuance of warrants. Issuance of Warrants Value Warrants issuance value The percentage of exercise price per share or per unit of warrants equal to common stock. Class of Warrant or Right, Exercise Price of Warrants or Rights, Percentage Equal to Common Stock Percentage of warrants equal to the closing price of common stock Number of securities into which the class of additional warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Class of Additional Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase additional common stock (in shares) An additional supplemental contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars. Additional Supplemental Line of Credit [Member] Promissory note executed on June 28, 2024 under the line of credit agreement. June 2024 Promissory Note [Member] June 2024 Promissory Note [Member] Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant Six [Member] Warrant Six [Member] Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant One [Member] Warrant One [Member] Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant Two [Member] Warrant Two [Member] Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant Seven [Member] Warrant Seven [Member] Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant Three [Member] Warrant Three [Member] Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant Five [Member] Promissory note executed on March 31, 2023 under the line of credit agreement. March 2023 Promissory Note [Member] Promissory note executed on June 30, 2023 under the line of credit agreement. December 2023 Promissory Note [Member] December 2023 Promissory Note [Member] Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant Four [Member] Latest expiration tax year. Expiring Through 2037 [Member] Expiring as a result of 2017 tax act earliest tax year. Expiring as a Result of 2017 Tax Act [Member] The deferred tax assets valuation allowance percentage in each of the last two years. Deferred Tax Assets Valuation Allowance Percentage Deferred tax asset valuation allowance percentage in each of the last two years Expiration year of each operating loss carryforward included in operating loss carryforward, in YYYY format. Operating Loss Carryforwards Expiration Year Operating loss carryforwards expiration year The federal and state research and development credits expiration year. Federal and State Research and Development Credits Expiration Year Federal and state research and development credits expiration year Percentage of weighted average stock price for dividends prior to payment date. Percentage of Weighted Average Stock Price for Dividends Prior to Payment Date Weighted average price percentage Refers to the terms of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but not limited to, weeks in a year or quarter. Share-based Compensation Arrangement by Share-based Payment Award, Term of Award Award term Clinical Trial and Research Contingencies [Abstract] Contract cancelation notice period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Contract Cancelation Notice Period Contract cancelation notice period Number of operating leases during period. Number of Operating Leases Number of operating leases Free rent period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Free Rent Period Free rent period Business operating segment which is focused on creating new therapies for fibrotic disease based on targeting galectin proteins. Business Operating Segment [Member] Business Operating Segment [Member]